John Simard - Jan 31, 2025 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
John Simard
Stock symbol
XBIT
Transactions as of
Jan 31, 2025
Transactions value $
-$24,703,550,000,000
Form type
4
Date filed
2/4/2025, 04:53 PM
Previous filing
Jan 5, 2024
Next filing
Mar 19, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIT Convertible Loan Agreement Other -$24.7T -2.47M -73.95% $10,000,000.00 870K Jan 31, 2025 Common Shares or Preferred Shares 2.47M $4.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 31, 2025, the Convertible Loan Agreement (the "Loan") dated as of January 3, 2024 between XBiotech Inc. and John Simard, the Company's Founder, President, Chief Executive Officer, and Chairman, was terminated upon full repayment of the Loan by the Company. As a result, all conversion rights to XBiotech stock associated with the Loan were extinguished.